- September-October 2017, Volume 14, Issue 5
In this issue, Dr. Moss covers practical issues to consider for CAR-T cell therapy; Dr. Jason Gotlib discusses the road to approval of midostaurin; Drs. Luke Maese and Joshua Schiffman discuss recommendations for childhood cancer predisposition syndromes; and Dr. Alan Rosmarin pays tribute to the life of Dr. H. Jean Khoury (1967-2017).
- July-August 2017, Volume 14, Issue 4
The Hematologist July August 2017
- May-June 2017, Volume 14, Issue 3
In this issue, Drs. Dietrich and Berube discuss their approach to the diagnosis and management of von Willebrand disease during pregnancy; Drs. Kantarjian, Keating, and Freireich cover six decades of history at MD Anderson's leukemia research program; Dr. Lori-Ann Linkins provides an update on a new study of apixaban; and Committee Chair Dr. Belinda Avalos reviews the critical initiatives and future goals of ASH's Committee on Promoting Diversity.
- March-April 2017, Volume 14, Issue 2
In this issue, ASH President Dr. Kenneth Anderson offers insight into the Society’s official policy statements; Drs. Stieglitz and Koegel discuss genetic markers and risk stratification algorithms to treat JMML; an Image Challenge presents the case of a 31-year-old man with thrombocytopenia since his teenage years; and Blood Editors and ASH staff commemorate the life and legacy of Professor Niels Borregaard (1951-2017).
- January-February 2017, Volume 14, Issue 1
In this issue, ASH President Dr. Kenneth Anderson ushers in 2017 spotlighting the Society’s education mission; The Hematologist’s Contributing Editors provide coverage on the top 12 most influential breakthroughs of 2016; Dr. John Mascarenhas discusses the PERSIST-2 trial and its future implications; and an Image Challenge presents the case of a 29-year-old with recurrent necrotizing pancreatitis and pancytopenia.